Video

Q&A With Rifka C. Schulman From North Shore LIJ: Using Pamidronate in Patients with Chronic Critical Illness

Author(s):

Patients with chronic critical illness face a litany of health issues after their treatment needing care for these conditions. While pamidronate has been used in the past a new study looked at whether the treatment affects areas like bone absorption and overall mortality and ventilator liberation.

Patients with chronic critical illness face a litany of health issues after their treatment needing care for these conditions. While pamidronate has been used in the past a new study looked at whether the treatment affects areas like bone absorption and overall mortality and ventilator liberation.

Rifka C. Schulman, MD from North Shore LIJ discussed the results of the study during the AACE's 24th Annual Scientific and Clinical Congress in Nashville. Schulman said the results showed that one eyear mortality was shown to improve with the medication and were more likely to be removed from the ventilator. They also showed better renal function whether they had normal or abnormal kidney function before treatment.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.